Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

Abbott Laboratories Asks Regulators to Approve New Dose of AIDS Drug Kaletra for Children

July 23, 2007

Abbott Laboratories on Friday said it is seeking approval from the U.S. Food and Drug Administration and European regulators for lower-dose versions of its AIDS drug Kaletra, which is also marketed as Aluvia. The new version is expected to be suitable for pediatric use and would cost half as much as the full-strength formulation.

Back to other news for July 2007

Adapted from:
Associated Press
7.20.2007


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More HIV News

Tools
 

Advertisement